These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20055694)

  • 1. Treatment of plaque psoriasis with the two-compound product calcipotriol/betamethasone dipropionate versus both monotherapies: an immunohistochemical study.
    van der Velden HM; Pasch MC; van Erp PE; van Lingen RG; Otero ME; de Boer-van Huizen RT; van de Kerkhof PC
    J Dermatolog Treat; 2010 Jan; 21(1):13-22. PubMed ID: 20055694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.
    Vissers WH; Berends M; Muys L; van Erp PE; de Jong EM; van de Kerkhof PC
    Exp Dermatol; 2004 Feb; 13(2):106-12. PubMed ID: 15009104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
    J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
    Kragballe K; Austad J; Barnes L; Bibby A; de la Brassinne M; Cambazard F; Fleming C; Heikkilä H; Jolliffe D; Peyri J; Svensson A; Toole J; Wozel G
    Br J Dermatol; 2006 Jun; 154(6):1155-60. PubMed ID: 16704648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    van de Kerkhof PC; Hoffmann V; Anstey A; Barnes L; Bolduc C; Reich K; Saari S; Segaert S; Vaillant L
    Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
    Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
    J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris.
    Kragballe K; Austad J; Barnes L; Bibby A; de la Brassinne M; Cambazard F; Fleming C; Heikkilä H; Williams Z; Peyri Rey J; Svensson A; Toole J; Wozel G
    Dermatology; 2006; 213(4):319-26. PubMed ID: 17135738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
    van de Kerkhof PC
    Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment.
    Rigopoulos D; Gregoriou S; Daniel Iii CR; Belyayeva H; Larios G; Verra P; Stamou C; Kontochristopoulos G; Avgerinou G; Katsambas A
    Dermatology; 2009; 218(4):338-41. PubMed ID: 19212110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland.
    Bottomley JM; Auland ME; Morais J; Boyd G; Douglas WS
    Curr Med Res Opin; 2007 Aug; 23(8):1887-901. PubMed ID: 17610804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial.
    Saraceno R; Andreassi L; Ayala F; Bongiorno MR; Giannetti A; Lisi P; Martini P; Peris K; Peserico A; Chimenti S
    J Dermatolog Treat; 2007; 18(6):361-5. PubMed ID: 17934937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once daily application of a combination of calcipotriol and betamethasone dipropionate (Dovobet, Daivobet) for the treatment of psoriasis.
    Lui H; Shapiro J
    Skin Therapy Lett; 2003; 8(Suppl 1):1-2. PubMed ID: 14961173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.
    Fleming C; Ganslandt C; Guenther L; Johannesson A; Buckley C; Simon JC; Stegmann H; Vestergaard Tingleff L
    Eur J Dermatol; 2010; 20(4):465-71. PubMed ID: 20413372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
    Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
    Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
    Ortonne JP; Ganslandt C; Tan J; Nordin P; Kragballe K; Segaert S
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):919-26. PubMed ID: 19453810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DESIRE study--psoriasis patients' satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice.
    Claréus BW; Houwing R; Sindrup JH; Wigchert S
    Eur J Dermatol; 2009; 19(6):581-5. PubMed ID: 19726275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
    Glade CP; Van Erp PE; Van De Kerkhof PC
    Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of psoriasis with a new combination of calcipotriol and betamethasone dipropionate: a flow cytometric study.
    van Rossum MM; van Erp PE; van de Kerkhof PC
    Dermatology; 2001; 203(2):148-52. PubMed ID: 11586014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.